Literature DB >> 22286915

Structure and ligand recognition of class C GPCRs.

Lei Chun1, Wen-hua Zhang, Jian-feng Liu.   

Abstract

The G-protein-coupled receptors (GPCRs) are one of the largest super families of cell-surface receptors and play crucial roles in virtually every organ system. One particular family of GPCRs, the class C GPCRs, is distinguished by a characteristically large extracellular domain and constitutive dimerization. The structure and activation mechanism of this family result in potentially unique ligand recognition sites, thereby offering a variety of possibilities by which receptor activity might be modulated using novel compounds. In the present article, we aim to provide an overview of the exact sites and structural features involved in ligand recognition of the class C GPCRs. Furthermore, we demonstrate the precise steps that occur during the receptor activation process, which underlie the possibilities by which receptor function may be altered by different approaches. Finally, we use four typical family members to illustrate orthosteric and allosteric sites with representative ligands and their corresponding therapeutic potential.

Mesh:

Substances:

Year:  2012        PMID: 22286915      PMCID: PMC4077135          DOI: 10.1038/aps.2011.186

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  98 in total

1.  Anxiolytic effects of a novel group II metabotropic glutamate receptor agonist (LY354740) in the fear-potentiated startle paradigm in humans.

Authors:  Christian Grillon; Jeremy Cordova; Louise R Levine; Charles A Morgan
Journal:  Psychopharmacology (Berl)       Date:  2003-04-23       Impact factor: 4.530

Review 2.  The metabotropic glutamate receptors: structure, activation mechanism and pharmacology.

Authors:  Jean-Philippe Pin; Francine Acher
Journal:  Curr Drug Targets CNS Neurol Disord       Date:  2002-06

Review 3.  Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors.

Authors:  Jean-Philippe Pin; Thierry Galvez; Laurent Prézeau
Journal:  Pharmacol Ther       Date:  2003-06       Impact factor: 12.310

Review 4.  G-protein-coupled receptor oligomerization and its potential for drug discovery.

Authors:  Susan R George; Brian F O'Dowd; Samuel P Lee
Journal:  Nat Rev Drug Discov       Date:  2002-10       Impact factor: 84.694

5.  Closure of the Venus flytrap module of mGlu8 receptor and the activation process: Insights from mutations converting antagonists into agonists.

Authors:  Anne-Sophie Bessis; Philippe Rondard; Florence Gaven; Isabelle Brabet; Nicolas Triballeau; Laurent Prezeau; Francine Acher; Jean-Philippe Pin
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-31       Impact factor: 11.205

6.  Identification of acidic residues in the extracellular loops of the seven-transmembrane domain of the human Ca2+ receptor critical for response to Ca2+ and a positive allosteric modulator.

Authors:  Jianxin Hu; Guadalupe Reyes-Cruz; Wangzhong Chen; Kenneth A Jacobson; Allen M Spiegel
Journal:  J Biol Chem       Date:  2002-09-23       Impact factor: 5.157

7.  Arylalkylamines are a novel class of positive allosteric modulators at GABA(B) receptors in rat neocortex.

Authors:  David I B Kerr; Jennifer Ong; Ni Made Puspawati; Rolf H Prager
Journal:  Eur J Pharmacol       Date:  2002-09-06       Impact factor: 4.432

8.  Three adjacent serines in the extracellular domains of the CaR are required for L-amino acid-mediated potentiation of receptor function.

Authors:  Zaixiang Zhang; Weiying Qiu; Stephen J Quinn; Arthur D Conigrave; Edward M Brown; Mei Bai
Journal:  J Biol Chem       Date:  2002-07-02       Impact factor: 5.157

9.  Potentiation of metabotropic GABAB receptors by L-amino acids and dipeptides in rat neocortex.

Authors:  David I B Kerr; Jennifer Ong
Journal:  Eur J Pharmacol       Date:  2003-05-09       Impact factor: 4.432

10.  Mutational analysis and molecular modeling of the allosteric binding site of a novel, selective, noncompetitive antagonist of the metabotropic glutamate 1 receptor.

Authors:  Pari Malherbe; Nicole Kratochwil; Frédéric Knoflach; Marie-Thérèse Zenner; James N C Kew; Claudia Kratzeisen; Hans P Maerki; Geo Adam; Vincent Mutel
Journal:  J Biol Chem       Date:  2002-12-30       Impact factor: 5.157

View more
  30 in total

1.  A new era for GPCR research: structures, biology and drug discovery.

Authors:  H Eric Xu; Rui-ping Xiao
Journal:  Acta Pharmacol Sin       Date:  2012-03       Impact factor: 6.150

2.  Structural architecture of a dimeric class C GPCR based on co-trafficking of sweet taste receptor subunits.

Authors:  Jihye Park; Balaji Selvam; Keisuke Sanematsu; Noriatsu Shigemura; Diwakar Shukla; Erik Procko
Journal:  J Biol Chem       Date:  2019-02-05       Impact factor: 5.157

3.  Discovery of a Negative Allosteric Modulator of GABAB Receptors.

Authors:  Lin-Hai Chen; Bing Sun; Yang Zhang; Tong-Jie Xu; Zhi-Xiong Xia; Jian-Feng Liu; Fa-Jun Nan
Journal:  ACS Med Chem Lett       Date:  2014-05-27       Impact factor: 4.345

4.  Dynamic roles for the N-terminus of the yeast G protein-coupled receptor Ste2p.

Authors:  M Seraj Uddin; Fred Naider; Jeffrey M Becker
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-07-25       Impact factor: 3.747

5.  MCCS, a novel characterization method for protein-ligand complex.

Authors:  Maozi Chen; Zhiwei Feng; Siyi Wang; Weiwei Lin; Xiang-Qun Xie
Journal:  Brief Bioinform       Date:  2021-07-20       Impact factor: 11.622

Review 6.  Allosteric modulation of Class C GPCRs: a novel approach for the treatment of CNS disorders.

Authors:  Darren W Engers; Craig W Lindsley
Journal:  Drug Discov Today Technol       Date:  2013

7.  The Heptahelical Domain of the Sweet Taste Receptor T1R2 Is a New Allosteric Binding Site for the Sweet Taste Modulator Amiloride That Modulates Sweet Taste in a Species-Dependent Manner.

Authors:  Meng Zhao; Xiang-Qun Xu; Xuan-Yu Meng; Bo Liu
Journal:  J Mol Neurosci       Date:  2018-08-17       Impact factor: 3.444

Review 8.  Osteocalcin in the brain: from embryonic development to age-related decline in cognition.

Authors:  Arnaud Obri; Lori Khrimian; Gerard Karsenty; Franck Oury
Journal:  Nat Rev Endocrinol       Date:  2018-01-29       Impact factor: 43.330

Review 9.  Allosteric modulators for the treatment of schizophrenia: targeting glutamatergic networks.

Authors:  Frank S Menniti; Craig W Lindsley; P Jeffrey Conn; Jayvardhan Pandit; Panayiotis Zagouras; Robert A Volkmann
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

Review 10.  Outside-in signaling--a brief review of GPCR signaling with a focus on the Drosophila GPCR family.

Authors:  Caitlin D Hanlon; Deborah J Andrew
Journal:  J Cell Sci       Date:  2015-09-07       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.